Clinical Trials: Find a Clinical Trial

At any time Memorial Sloan-Kettering Cancer Center is conducting hundreds of clinical trials to improve care for many types of cancer. Use the tool below to browse our clinical trials that are currently enrolling new patients. Each listing explains the purpose of the trial, the trial’s eligibility criteria, and how to get more information.

The list below includes clinical trials for adult cancers. Please visit our pediatric cancer care section to find a pediatric clinical trial.

Showing 181 - 200 of 454 trials
Title Investigatorsort icon Disease(s)
A Phase II Study of PET Scan-Directed Combined Modality Therapy for Esophageal Cancer
[Protocol 12-011]
Ilson, David
  • Upper Gastrointestinal
    • Esophageal Cancer
A Phase II Study of Afatinib (BIBW 2992) in Patients with Advanced HER2-Positive Esophagogastric Cancer Refractory to Trastuzumab
[Protocol 11-166]
Janjigian, Yelena
  • Upper Gastrointestinal
    • Esophageal Cancer
    • Gastric Cancer
A Randomized Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) Treatment versus Conventional DCF with Growth Factor Support in Patients with Unresectable or Metastatic Gastric and Gastroesophageal Junction Cancer
[Protocol 06-103]
Janjigian, Yelena
  • Upper Gastrointestinal
    • Gastric Cancer
A Phase II Study of Hepatic Arterial Infusion with Floxuridine and Dexamethasone plus Systemic Gemcitabine and Oxaliplatin in Patients with Inoperable Intrahepatic Cholangiocarcinoma
[Protocol 13-066]
Jarnagin, William
  • Hepatobiliary
    • Liver Cancer
A Phase III Study of Radiation Therapy with and without Temozolomide for Symptomatic or Progressive Low-Grade Gliomas
[Protocol 11-120]
Kaley, Thomas
  • Brain Tumors, Primary
    • Gliomas
  • Pediatric Brain Tumors
    • Brain Cancer
Early Onset and Familial Gastric Cancer Registry
[Protocol 05-118]
Kelsen, David
  • Hereditary Cancer & Genetics
  • Upper Gastrointestinal
    • Gastric Cancer
A Phase II Study of Hepatic Arterial Infusion and Intravenous Chemotherapy with or without Panitumumab in Patients with Normal KRAS with Resected Liver Metastases from Colorectal Cancer
[Protocol 10-137]
Kemeny, Nancy
  • Colorectal Cancer
A Phase II Study of Sunitinib or Cediranib for Inoperable Metastatic Alveolar Soft Part Sarcoma
[Protocol 12-095]
Keohan, Mary
  • Sarcomas
    • Soft Tissue Sarcoma
Defibrotide for Patients with Hepatic Veno-Occlusive Disease
[Protocol 08-060]
Kernan, Nancy
  • Blood and Marrow Transplantation
    • Transplantation
A Phase I Study of Modified T Cells Targeted to CD19-Positive Acute Lymphoblastic Leukemia Relapsing After Allogeneic Stem Cell Transplantation
[Protocol 11-038]
Kernan, Nancy
  • Leukemia
    • Acute Lymphoblastic Leukemia
A Survey of Psychosocial Needs and Exploration of Online Support for Patients with Pleural Mesothelioma
[Protocol 11-066]
Key, Richard
  • Mesothelioma
A Phase II Study of Sunitinib to Treat High-Grade Glioma and Ependymoma Tumors in Pediatric and Young Adult Patients
[Protocol 13-026]
Khakoo, Yasmin
  • Brain Tumors, Primary
    • Gliomas
    • Other Trials
  • Pediatric Brain Tumors
    • Brain Cancer
A Phase III Study of the Value of Early Local Therapy for the Intact Primary Tumor in Patients with Metastatic Breast Cancer
[Protocol 11-190]
King, Tari
  • Breast Cancer
A Phase III Study of Cytarabine with or without Vosaroxin in Patients with First Relapsed or Refractory Acute Myeloid Leukemia
[Protocol 11-094]
Klimek, Virginia
  • Leukemia
    • Acute Myelogenous Leukemia
A Phase IIB Study of 5-Azacitidine with or without Panobinostat in Patients with Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, and Acute Myeloid Leukemia
[Protocol 12-219]
Klimek, Virginia
  • Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
    • Chronic Myelocytic Leukemia
    • Myelodysplastic Syndrome
A Phase III Study of Lenalidomide Alone and in Combination with Epoetin Alfa in Patients with Myelodysplastic Syndromes and Symptomatic Anemia
[Protocol 10-128]
Klimek, Virginia
  • Hematology
    • Myelodysplastic Syndrome
  • Leukemia
    • Myelodysplastic Syndrome
A Phase II Study of New Treatment Approaches for High-Risk Renal Tumors
[Protocol 12-026]
Kobos, Rachel
  • Kidney Cancer
  • Sarcomas
Treatment for Very Low-Risk and Standard-Risk Favorable Histology Wilms Tumor
[Protocol 12-084]
Kobos, Rachel
  • Kidney Cancer
Treatment of Newly Diagnosed Higher Risk Favorable Histology Wilms Tumors
[Protocol 12-114]
Kobos, Rachel
  • Kidney Cancer
Renal Tumor Classification, Biology, and Banking Study
[Protocol 12-014]
Kobos, Rachel
  • Kidney Cancer